Viral Vector Therapeutics, Gene Therapy
Angionetics Inc., is a company focused on the late-stage clinical development and commercialization of Generx®, an angiogenic gene therapy product candidate designed for medical revascularization ...
custom-made recombinant viral vectors
AAV Gene Therapy Treatments
Gene silencing technology
Adeno-Associated Virus Delivery, Gene Therapy
Gene therapies for rare and orphan neurological genetic diseases
BEAT Biotherapeutics Corp. (BEATBio) is developing BB-R12, a novel gene therapy with the potential to revolutionize the treatment of heart failure.
Develops next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), CAR T cell therapy, and TCR ...
A biopharmaceutical company. They discover, develop, and deliver medicines to treat serious disease.
Designing next generation immunotherapies based on gene-edited CAR T-cells
Gene Therapy, Orphan Diseases
Gene Transfer Technology
Gene Therapy platform technology
Gene Therapy for Cancer
Engineers B cells through gene therapy to produce proteins that combat disease.
Gene Therapy or 'genomic medicine'
Gene therapy cancer treatment
Gene shuffling technology
Site-Specific Gene Modification System
Plasmid and Adenovirus Purification
Gene Therapy, Biologics
We are Sarepta Therapeutics: a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics. Our goal is to harness the power of cutting-edge technology
to improve ...
Singe Dose Gene Therapy
Uses recombinant Adeno-associated virus to engineer and edit genomes and make universal donor cells.